Skip to Content
  • One and Done

    Matthew Herper has a good piece in Forbes on Robert Duggan and Pharmacyclics. In the course of it, we learn this interesting (and perhaps disturbing) bit of inf… Read More
  • Ancient Modeling

    I really got a kick out of this picture that Wavefunction put up on Twitter last night. It’s from a 1981 article in Fortune, and you’ll just have to… Read More
  • Startups vs. Big Pharma

    Bruce Booth has opened up the number of authors who will be posting at LiveSciVC, and there’s an interesting post up on startups now from Atlas Ventures&# Read More
  • Drug Discovery in India

    Molecular biologist Swapnika Ramu, a reader from India, sends along a worthwhile (and tough) question. She says that after her PhD (done in the US), her return… Read More
  • A New Look At Clinical Attrition

    Thanks to this new article in Nature Biotechnology, we have recent data on the failure rates in drug discovery. Unfortunately, this means that we have recent da… Read More
  • The Old AstraZeneca Charnwood Site

    Trying to find tenants for the former AstraZeneca campus at Charnwood. A few buildings are being demolished to make room, and they’re hoping for biomedica… Read More
Page 10 of 39« First...89101112...2030...Last »